Edward Wenge Wang, M.D., Ph.D., is an assistant professor in the department of Medical Oncology, specializing in gynecologic oncology.
Dr. Wang earned his undergraduate degree in medicine, followed by a Master of Science degree in immunology and a Ph.D. in tumor immunology, from Harbin Medical University in Harbin, China. He completed postdoctoral research at Columbia University in New York, before moving to Philadelphia to serve as a Research Associate at the Howard Hughes Medical Institute, while also serving as Senior Research Investigator at the University of Pennsylvania.
After a brief time as Director of Projects for the Cancer Institute at Penn State Hershey Medical Center, Dr. Wang successfully completed postgraduate training with an internship and residency in internal medicine at Mount Vernon Hospital in New York, and Banner-University Medical Center in Phoenix, Arizona, respectively. He completed his Hematology Oncology fellowship training at Penn State Hershey Medical College in Pennsylvania.
Dr. Wang has authored 35 scholarly articles and has been an invited lecturer at symposiums and conferences across the country. His research interests include: molecular targeting of p53-dictated cell death pathways for cancer treatment; exploration of the mechanism of DNA interaction-mediated p53 activation; targeting death receptor trafficking and signaling to reverse TRAIL resistance; bringing TRAIL and agonist antibodies back to clinical trials; and clearance of MCL-1-mediated cell survival signals to facilitate cancer cell death induced by intrinsic or extrinsic apoptotic pathways. In 2002, Dr. Wang received the AACR/AFLAC Scholar-in-Training Award at the American Association for Cancer Research Annual Meeting in San Francisco.